"If the pharmaceutical industry had developed a single drug capable of reducing cancer mortality by 25%, autoimmune disorders by 39%, and COVID-19 infection rates by 74%, it would be heralded as a miracle drug."
Data revealed that levothyroxine users experienced greater bone loss even with normal TSH levels, prompting researchers to question current treatment guidelines for the second most prescribed medication among older adults.
Metformin was associated with a reduced risk of asthma attacks independent of glycemic control and weight loss and occurred across all phenotypes, including those with blood eosinophilia or not, and in all levels of asthma severity.
The USPSTF's draft recommendations reaffirm osteoporosis screening for older women, call for more research on screening men, and address health disparities.
A 20-year study reveals that patients with osteoarthritis have a higher risk of severe multimorbidity, emphasizing the need for comprehensive health care strategies beyond joint health.